Mazumdar Claire

Track

Insider profile

Mazumdar Claire's trades of Bicara Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-14 2026-07-10
PlS Planned sale
36,637 +25.8%
290.30
US$3,427,696 		36,637 +25.8% 290.30 US$3,427,696
2026-07-14 2026-07-10
PlS Planned sale
6,823 +19.2%
178.37
US$4,067,745 		6,823 +19.2% 178.37 US$4,067,745
2026-07-10 2026-07-10
PrS Proposed sale
61,872
466.51
US$1,678,887 		61,872 466.51 US$1,678,887
2026-05-20 2026-05-18
PlS Planned sale
2,978 -0.8%
20.35
US$60,597 		2,978 -0.8% 20.35 US$60,597
2026-05-20 2026-05-18
PlS Planned sale
12,022 -3.2%
19.96
US$239,982 		12,022 -3.2% 19.96 US$239,982
2026-05-18 2026-05-18
PrS Proposed sale
15,000
20.92
US$313,800 		15,000 20.92 US$313,800
2026-05-18 2026-05-18
PrS Proposed sale
15,000
20.92
US$313,800 		15,000 20.92 US$313,800
2026-04-20 2026-04-20
PlS Planned sale
15,000 -4.0%
23.61
US$354,146 		15,000 -4.0% 23.61 US$354,146
2026-04-20 2026-04-20
PrS Proposed sale
15,000
23.74
US$356,100 		15,000 23.74 US$356,100
2026-03-20 2026-03-20
PlS Planned sale
1,596 -0.5%
18.95
US$30,246 		1,596 -0.5% 18.95 US$30,246
2026-03-20 2026-03-20
PrS Proposed sale
1,596
18.95
US$30,246 		1,596 18.95 US$30,246
2026-03-20 2026-03-19
PlS Planned sale
6,905 -2.0%
18.78
US$129,705 		6,905 -2.0% 18.78 US$129,705
2026-03-19 2026-03-19
PrS Proposed sale
6,905
18.78
US$129,705 		6,905 18.78 US$129,705
2026-03-20 2026-03-18
PlS Planned sale
6,499 -1.9%
18.84
US$122,415 		6,499 -1.9% 18.84 US$122,415
2026-03-18 2026-03-18
PrS Proposed sale
6,499
19.19
US$124,716 		6,499 19.19 US$124,716
2026-03-11 2026-03-09
PlS Planned sale
36,766 -9.8%
19.17
US$704,657 		36,766 -9.8% 19.17 US$704,657
2026-03-09 2026-03-09
PrS Proposed sale
36,766
19.17
US$704,657 		36,766 19.17 US$704,657
2026-03-06 2026-03-06
PlS Planned sale
3,817 -1.1%
18.75
US$71,572 		3,817 -1.1% 18.75 US$71,572
2026-03-06 2026-03-06
PrS Proposed sale
3,817
19.80
US$75,572 		3,817 19.80 US$75,572
2026-03-06 2026-03-05
PlS Planned sale
1,786 -0.5%
18.74
US$33,464 		1,786 -0.5% 18.74 US$33,464
2026-03-05 2026-03-05
PrS Proposed sale
1,786
18.74
US$33,464 		1,786 18.74 US$33,464
2026-03-06 2026-03-04
PlS Planned sale
2,631 -0.8%
18.73
US$49,289 		2,631 -0.8% 18.73 US$49,289
2026-03-04 2026-03-04
PrS Proposed sale
2,631
18.73
US$49,289 		2,631 18.73 US$49,289
2025-11-25 2025-11-24
PlS Planned sale
41,163 -11.7%
18.86
US$776,429 		41,163 -11.7% 18.86 US$776,429
2025-11-24 2025-11-24
PrS Proposed sale
41,163
18.86
US$776,429 		41,163 18.86 US$776,429
2025-10-20 2025-10-16
PlS Planned sale
24,103 -7.2%
18.83
US$453,761 		24,103 -7.2% 18.83 US$453,761
2025-10-16 2025-10-16
PrS Proposed sale
24,103
18.83
US$453,761 		24,103 18.83 US$453,761
2025-10-15 2025-10-15
PrS Proposed sale
13,289
18.84
US$250,391 		13,289 18.84 US$250,391
2025-10-15 2025-10-15
PlS Planned sale
13,289 -4.1%
18.84
US$250,391 		13,289 -4.1% 18.84 US$250,391
2025-10-15 2025-10-13
PlS Planned sale
11,445 -3.6%
18.92
US$216,545 		11,445 -3.6% 18.92 US$216,545
2025-10-14 2025-10-13
PrS Proposed sale
11,445
18.92
US$216,545 		11,445 18.92 US$216,545